Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
WW InternationalWW +13.24%14 EV-to-EBIT is 0.44 as of Aug. 03, 2026, which is at its 10-year median of 0.44. GuruFocus rates WW with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 470 Healthcare Providers & Services companies, WW International ranks better than 98.3% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
WW International's Enterprise Value for the quarter that ended in Mar. 2026 was $484.7 Mil.
WW International's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,147.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WW International EV-to-EBIT Related Terms
WW International EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for WW International's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, WW International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WW International EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WW International's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where WW International's EV-to-EBIT falls into.
WW International's current Enterprise Value is $508.1 Mil.
WW International's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,147.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WW International (WW) has a EV-to-EBIT of 0.44 as of Aug. 03, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on WW International and its competitors. This is near median its historical median of 0.44. Over the past decade, WW International's EV-to-EBIT has ranged from 0.24 to 0.54. According to the industry distribution chart, WW International ranks #8 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 1.7%.
Is WW International's EV-to-EBIT too high?
WW International's current EV-to-EBIT of 0.44 is near median its 10-year median of 0.44. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 0.54. The Healthcare Providers & Services industry median EV-to-EBIT is 15.85. WW International's value of 0.44 is 97.2% below this industry median. Based on the distribution chart, WW International ranks #8 out of 470 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WW International has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does WW International's EV-to-EBIT compare to JYNT and PARK?
According to the Healthcare Providers & Services industry distribution chart, WW International ranks #8 out of 470 companies for EV-to-EBIT. This places WW International in the top 2% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.85. WW International's value of 0.44 is 97.2% below this benchmark. Historically, WW International's own EV-to-EBIT has ranged from 0.24 to 0.54 over the past decade. While the company's 10-year median is 0.44 vs. the industry median of 15.85, WW International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.85, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WW International's current EV-to-EBIT of 0.44 is 97.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on WW International and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WW International's current EV-to-EBIT is 0.44, which is near median its own 10-year median of 0.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WW International stock overvalued right now?
WW International (WW) has a current EV-to-EBIT of 0.44. The current EV-to-EBIT is 0.44, which is near median its 10-year median of 0.44 and 97.2% below the Healthcare Providers & Services industry median of 15.85. WW International's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For WW International (WW), the current EV-to-EBIT is 0.44 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
WW International Inc specializes in weight management and providing clinical solutions in the United States. it also operates its proprietary digital platform that provides members with access to science-backed behavioral weight loss and weight management programs. The company's primary sources of revenue are subscriptions for digital, workshop, and clinical offerings. The Digital business refers to providing subscriptions to digital product offerings. Workshops + Digital business provides subscriptions for unlimited access to workshops combined with digital subscription product offerings. The Clinical business provides subscriptions to clinical product offerings combined with digital subscription product offerings and unlimited access to workshops.
14GF Score
Get the complete analysis for WW
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WW has been successfully added to your 
